Liver-specific inhibition of ChREBP by shRNA silencing in obese and insulin-resistant, leptin mutant ob/ob mice decreased hepatic steatosis, plasma triglycerides, and non-esterified fatty acids. The gene discussed is MLXIPL; the disease is Hepatic steatosis.